These data indicate that LOX may serve as an intermediate signaling molecule linking HIF-1α to E-cadherin, the major structural protein of the adherens junction whose suppression is a well-known prerequisite for tumor cell invasion. The gene discussed is LOX; the disease is neoplasm.